Ideas & Insights

The DoD has updated its DFARS rules from the existing clause to three new clauses to allow enforcement of CMMC for DoD contracts.

More promise, more problems: Cyberattacks threaten life sciences companies researching COVID-19 vaccine.

The AICPA released the SOC for Supply Chain report to aid organizations with relevant controls to address business risk.

Life sciences companies: Learn the importance of anticipating and managing key risks when working with third parties in our helpful e-book.

What can life sciences businesses do to ensure data protection, especially with their third parties? Get key cybersecurity considerations.

Life sciences organizations are collecting customer data at an enormous rate leaving them vulnerable to cyberattacks.

Check out the recording below to learn how to position a security program to respond to cybersecurity threats in the life sciences industry.

How can life sciences businesses ensure a successful enterprise resource planning selection and launch? Research product, partner and costs.

RSM’s life sciences industry insider shares key insights and benefits of conducting a third-party contract compliance audit.

Third parties provide a vital business partnership for growing life sciences companies, but there are risks to consider.

Royalty review discovers omitted products, unallowable deductions, unreported sales and nearly $4.5 million in underpaid royalties.

Download the infographic to learn more about triggers that may warrant a contract compliance audit in the life sciences industry.

Missed the webcast on third-party risk management for life sciences companies? Check out this recorded webcast.